Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | MGAM | O43451 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | SI | P14410 | 1/20 | 0.42 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.42 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.42 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | KDR | P35968 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | PPM1B | O75688 | 1/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL52299 | 0.92 | — | — | |
| SCHEMBL28046444 | 0.92 | HCAR2 (0.52) | HCAR2ALDH1A1LMNAHSD17B10GAA | |
| SCHEMBL4344436 | 0.90 | ALDH1A1 (0.62) | HCAR2ALDH1A1LMNAHSD17B10ALOX15 | |
| SCHEMBL25428151 | 0.90 | ALDH1A1 (0.55) | HCAR2ALDH1A1LMNAHSD17B10ALOX15 | |
| SCHEMBL4665157 | 0.89 | — | — | |
| SCHEMBL7007667 | 0.89 | — | — | |
| SCHEMBL28379829 | 0.89 | — | — | |
| SCHEMBL4698697 | 0.89 | — | — | |
| Butane SCHEMBL5275061 | 0.89 | HCAR2 (0.50) | HCAR2ALDH1A1LMNAHSD17B10GAA | |
| Hydrochloric Acid SCHEMBL11851759 | 0.89 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230327205-A1 | ISATIN DERIVATIVE REDOXAMER FOR ELECTROCHEMICAL DEVICE | UCHICAGO ARGONNE, LLC. (US) | 2023-10-12 | — | — | US | disclosed |
| US-11715844-B2 | Isatin derivative redoxmer for electrochemical device | UCHICAGO ARGONNE, LLC (US) | 2023-08-01 | — | — | US | disclosed |
| WO-2022116170-A1 | ELECTROLYTE, AND ELECTROCHEMICAL DEVICE AND ELECTRONIC DEVICE COMPRISING ELECTROLYTE | 宁德新能源科技有限公司 | 2022-06-09 | — | — | WO | disclosed |
| EP-0030630-A2 | 7-Acylamino-3-vinylcephalosporanic acid derivatives, processes for their preparation, pharmaceutical compositions containing them; their starting compounds and their preparation | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1981-06-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230327205-A1 | ISATIN DERIVATIVE REDOXAMER FOR ELECTROCHEMICAL DEVICE | NDUFS5, SQOR, NDUFS7 | HCAR2 3816/4885ALDH1A1 1221/4885LMNA 4658/4885 |
| US-11715844-B2 | Isatin derivative redoxmer for electrochemical device | SQOR, SLC39A14, NDUFS5 | HCAR2 3743/4885ALDH1A1 630/4885LMNA 4650/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.